To test the hypothesis that MGMT promoter status varies with time of day in GBM cells of different backgrounds, we first assessed whether Mgmt promoter methylation varies with circadian time in murine (Nf1−/−DNp53), human (LN229), and primary (B165) GBM cells in vitro. Here, MGMT is linked to glioblastoma.